Tekmira files IND with FDA
August 5, 2010 by leonardzehr · Leave a Comment
Tekmira Pharmaceuticals (TSX:TKM) has filed an investigational new drug application seeking approval from the FDA to begin a Phase 1 clinical trial to evaluate PLK1 SNALP as a treatment for solid tumour cancers. “This is another important milestone for Tekmira as we continue to both advance our own pipeline of RNA-interference drug candidates and support our [...]
Listen to BioTuesdays 
